Cervical cancer cell–derived angiopoietins promote tumor progression
Metastatic or recurrent cervical cancer has limited treatment options and a high rate of mortality. Although anti-vascular endothelial growth factor drugs have shown great promise as a therapeutic target for treatment of advanced cervical cancer, drug resistance and class-specific side effects negat...
Saved in:
| Main Authors: | Ping Yang, Na Chen, Dongyun Yang, Janet Crane, Bangxing Huang, Ruiqing Dong, Xiaoqing Yi, Jing Guo, Jing Cai, Zehua Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-07-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317711658 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CDK12 Promotes Cervical Cancer Progression through Enhancing Macrophage Infiltration
by: Bikang Yang, et al.
Published: (2021-01-01) -
Arsenic trioxide inhibits angiogenesis of hepatocellular carcinoma after insufficient radiofrequency ablation via blocking paracrine angiopoietin-1 and angiopoietin-2
by: Shuying Dong, et al.
Published: (2022-12-01) -
Tumor‐derived endomucin promotes colorectal cancer proliferation and metastasis
by: Qi Huang, et al.
Published: (2023-02-01) -
Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma
by: Alexander Scholz, et al.
Published: (2015-12-01) -
Angiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential
by: Michael Whitehead, et al.
Published: (2019-01-01)